Can perindopril (angiotensin-converting enzyme inhibitor) cause diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Perindopril Cause Diarrhea?

Yes, perindopril can cause diarrhea, though it occurs infrequently as a direct adverse effect (reported in approximately 4-5% of patients), and more rarely as part of serious gastrointestinal angioedema.

Direct Gastrointestinal Side Effects

According to the FDA drug label, diarrhea is a recognized adverse effect of perindopril, occurring in 4.3% of patients in U.S. placebo-controlled trials 1. This represents a relatively uncommon but documented side effect that typically does not require drug discontinuation. In a Chinese study, diarrhea occurred in 5% of patients treated with perindopril 2.

The mechanism appears related to ACE inhibitor effects on bradykinin metabolism and prostaglandin release, which can affect gastrointestinal motility and secretion.

Serious Gastrointestinal Manifestations

More concerning is ACE inhibitor-induced gastrointestinal angioedema, a rare but potentially serious complication that presents with abdominal pain, nausea, vomiting, and diarrhea 3, 4, 5. While most case reports involve other ACE inhibitors like lisinopril, this is considered a class effect affecting all ACE inhibitors including perindopril 3.

Key Features of ACE Inhibitor-Induced GI Angioedema:

  • Presentation: Abdominal pain with nausea, vomiting, and/or diarrhea
  • Timing: Unpredictable—can occur within weeks or after years of therapy 5
  • Imaging findings: Small bowel wall thickening and ascites on CT scan 3, 4
  • Demographics: Increased incidence in African American women 3
  • Resolution: Symptoms typically improve within 48-72 hours after drug discontinuation 4

Rare Collagenous Colitis

A single case report documented perindopril-induced collagenous colitis with chronic diarrhea and hypokalemia 6. The patient developed diarrhea 3 weeks after starting perindopril, with resolution within 3 days of discontinuation and histologic normalization at 4 months.

Clinical Management Algorithm

If a patient on perindopril develops diarrhea:

  1. Mild, isolated diarrhea (no other symptoms):

    • Consider symptomatic management
    • Monitor for persistence or worsening
    • Rule out other causes (infections, dietary changes, other medications)
  2. Diarrhea with abdominal pain, nausea, or vomiting:

    • Immediately consider ACE inhibitor-induced GI angioedema
    • Obtain CT abdomen/pelvis looking for small bowel wall thickening and ascites
    • Discontinue perindopril immediately if imaging suggests angioedema
    • Provide supportive care with IV fluids
    • Symptoms should improve within 48 hours if drug-related
  3. Chronic diarrhea with hypokalemia:

    • Consider colonoscopy with biopsies to evaluate for microscopic colitis
    • Discontinue perindopril if collagenous colitis confirmed

Important Caveats

  • Do not rechallenge with perindopril or any other ACE inhibitor if GI angioedema is diagnosed—recurrence is highly likely 3
  • Consider switching to an angiotensin receptor blocker (ARB) as an alternative, though cross-reactivity can rarely occur
  • The FDA label warns that inadequate fluid intake or excessive diarrhea can lead to excessive blood pressure drops in patients on ACE inhibitors 1
  • African American women appear at higher risk for GI angioedema 3

Bottom line: While simple diarrhea from perindopril is uncommon and usually mild, any patient on perindopril presenting with diarrhea plus abdominal pain should be evaluated urgently for potentially serious GI angioedema, which requires immediate drug discontinuation.

Related Questions

Can you interpret the laboratory results for my 73‑year‑old patient who presents with a persistent non‑productive cough after lisinopril, chronic constipation, weight loss, orthostatic dizziness, intermittent abdominal pain, dysphagia‑like sensation, low energy, memory lapses, and subclinical hypothyroidism?
What is the most likely cause of post‑prandial abdominal pain in a 73‑year‑old woman with multiple drug allergies who is taking acetaminophen, tuberculin (twice daily), estrin, fluticasone, fosfomycin, ginger, niacin, prednisone, rosuvastatin, levothyroxine (Synthroid), and tirzepatide (Zepbound)?
In a 50-year-old male with chronic mild plaque psoriasis of the elbows and knees who is no longer responding to intermittent calcipotriene 0.5% cream, what outcomes and side effects can be expected when initiating a topical vitamin D analog (calcipotriene) as maintenance therapy?
How should a 60-year-old female with a total cholesterol of 226 mg/dL, HDL cholesterol of 51 mg/dL, and triglycerides of 202 mg/dL be managed?
How should a 36-year-old woman with acute right lower quadrant abdominal pain, normal vital signs, negative urine pregnancy test, no fever, vomiting, dysuria, or vaginal discharge, and physical exam showing right lower quadrant tenderness with guarding on muscle contraction (positive McBurney's sign) but no rebound or peritoneal signs and a pelvic exam without cervical motion tenderness or mass be evaluated and managed?
What is the recommended daily intake of saturated fat?
Is it safe to use Betaderm (betamethasone dipropionate 0.05%) in children, and what are the recommended dosage, duration, and precautions?
Which over-the-counter (OTC) medications can cause an elevated post-void residual urine volume?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.